← All diseases Cancer

Liver cancer

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the most robust evidence (78)Meta-analysis (34)Treatment guideline (5)Systematic review (18)Randomized trial (14)Phase 3 study (7)Clinical trial (608)Review article (444)Early study (phase 1 or 2) (26)Laboratory or animal research (164)Case report (107)Commentary or editorial (68)Retracted publication (8)Concerns have been raised (1) Studies currently recruiting participants only (41)

Filter

Publications and studies (3362)

• Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinoma. (2017/12/15) ♡
• Non coding RNA analysis in fibrolamellar hepatocellular carcinoma. (2017/12/15) ♡
• Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers. (2017/12/13) ♡
• The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis. (2017/12/11) ♡
• Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma. (2017/12/08) ♡
• Computed Tomographic Perfusion Imaging for the Prediction of Response and Survival to Transarterial Chemoembolization of Hepatocellular Carcinoma. (2017/12/07) ♡
• Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. (2017/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma. (2017/12/05) ♡
• Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling. (2017/12/04) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine. (2017/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Antitumor Activity of the Chinese Medicine JC-001 Is Mediated by Immunomodulation in a Murine Model of Hepatocellular Carcinoma. (2017/12/01) ♡
• Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. (2017/12/01) ♡
• Genotoxic potential of the binary mixture of cyanotoxins microcystin-LR and cylindrospermopsin. (2017/12/01) ♡
• Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. (2017/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Liver Transplantation From a Donor With a Continuous-Flow Left Ventricular Assist Device for 9 Months. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutrition and Muscle in Cirrhosis. (2017/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history. (2017/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Landscape of genomic alterations in hepatocellular carcinoma: current knowledge and perspectives for targeted therapies. (2017/12/01) ♡
• Managing the Burden of Non-NASH NAFLD. (2017/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Approaches for safe transarterial chemoembolization of multifocal hepatocellular carcinoma with retrograde flow in a retroportal artery. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma. (2017/12/01) ♡
• Ultra-Low-Dose Sparse-View Quantitative CT Liver Perfusion Imaging. (2017/12/01) ♡
• Significance of growth differentiation factor 15 in chronic HCV patients. (2017/12/01) ♡
• C21 steroid-enriched fraction refined from Marsdenia tenacissima inhibits hepatocellular carcinoma through the coordination of Hippo-Yap and PTEN-PI3K/AKT signaling pathways. (2017/11/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. FOXC1, the new player in the cancer sandbox. (2017/11/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Non-alcoholic liver disease - diagnosis and treatment]. (2017/11/23) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. (2017/11/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress on the forkhead box C1. (2017/11/20) ♡
• Identification of WT1 as determinant of hepatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde. (2017/11/11) ♡
• Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1. (2017/11/06) ♡
• Coumarins from the bark of Juglans mandshurica exhibited anti-hepatoma activities via inducing apoptosis. (2017/11/01) ♡
• Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214. (2017/11/01) ♡
• [Radix Angelicae Sinensis and Radix Hedysari Enhance Radiosensitivity of Human Liver Cancer Cells to ¹²C⁶⁺Radiation]. (2017/11/01) ♡
• Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer. (2017/11/01) ♡
• Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma. (2017/11/01) ♡
• Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. (2017/11/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate. (2017/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. De novo hepatocellular carcinoma post-multivisceral transplantation in a child. (2017/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications. (2017/11/01) ♡
• Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer. (2017/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Two Cases of Hepatocellular Carcinoma Skin Metastasis]. (2017/11/01) ♡
• Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma. (2017/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Right upper pulmonary vein metastasis from hepatocarcinoma. (2017/10/31) ♡
• Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based Multiplex Serological Assay. (2017/10/30) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Radiosensitizing effect of ellagic acid on growth of Hepatocellular carcinoma cells: an in vitro study. (2017/10/25) ♡
• Neutrophil-lymphocyte Ratio Plus Prognostic Nutritional Index Predicts the Outcomes of Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization. (2017/10/24) ♡
• Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis. (2017/10/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements. (2017/10/21) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury. (2017/10/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper. (2017/10/18) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.